ArticleFrontiers in public health2022

Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario.

Henrry Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.